AstraZeneca Share Price (AZN)

4,753.00 -19.00 (-0.40%) delayed: 6:06AM GMT
Bid price 4,752.00 Open price 4,767.50
Ask price 4,754.00 Prev close 4,752.00
High price 4,791.00 Spread 0.04%
Low price 4,710.50 Volume 1,836,745

Register now for FREE live AstraZeneca share prices, AstraZeneca stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get AstraZeneca Level 2 Data, indepth research tools and investor commentary for AstraZeneca (AZN) and other London Stock Exchange equities.

AstraZeneca Share Price Chart

Advanced Charts >>

Register now for FREE AstraZeneca share price charts

AstraZeneca Share Price Information

Name AstraZeneca Epic AZN
Sector Pharmaceuticals & Biotechnology ISIN GB0009895292
Activites AstraZeneca plc is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Index FTSE 100

AstraZeneca Key Numbers

Latest Share Price (p) 4,753.00 Net Gearing (%) 68.49
Market Capitalisation (£m) 60,780.67 Gross Gearing (%) 73.73
Shares in issue (m) 1,266.40 Debt Ratio 64.57
P/E Ratio 20.25 Debt-to-Equity Ratio 0.65
Total dividends per share (p) 202.50 Assets / Equity Ratio 3.81
Dividend Yield (%) 4.22 Price to book value 3.65
Dividend cover (x) 1.17 ROCE (%) 4.74
Earning per share (p) 237.00 EPS Growth (%) -14.44
52 week high / low 5,520.00 / 4,260.00 DPS Growth (%) -7.49

AstraZeneca Director Deals

Dec.Date Type Director Pos No. of Shares
05/02/2018 BUY Philip Broadley FD 415
15/12/2017 TOUT Pascal Soriot CEO 39,648
28/07/2017 BUY Philip Broadley FD 2,300
28/07/2017 BUY Prof Nazneen Rahman NED 500
16/05/2017 TOUT Pascal Soriot CEO 163,000

More AstraZeneca Director Deals >>

AstraZeneca Company News

13:07 23/02/2018

AstraZeneca, Merck ovarian cancer treatment gets European nod

AstraZeneca and Merck & Co. said European authorities had recommended a marketing authorization be granted for Lynparza, a treatment for epithelial ovarian, fallopian tube, or primary peritoneal cancer. 'The data show that Lynparza provides long-term disease control, delaying the need for...

12:35 23/02/2018

Lynparza CHMP for ovarian cancer maintainance

RNS Number : 8137F AstraZeneca PLC 23 February 2018   This announcement contains inside information   23 February 2018 12:30 BST   LYNPARZA RECEIVES POSITIVE EU CHMP OPINION IN  PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER AstraZeneca and MSD's new...

11:55 19/02/2018

FTSE falls flat on weaker miners

A strong performance in Asia this morning failed to fuel the FTSE 100, with weakness in miners holding back any positive momentum. Gold miner Randgold Resources (RRS) retreated 1.3% to £62.20 and Fresnillo (FRES) nudged 1% lower to £13.85. Another key faller was consumer products colossus...

More AstraZeneca Company News >>

Register now for FREE AstraZeneca company news

AstraZeneca Share Price Discussions

7 months ago

Any views on Astrazeneca (AZN)

Got a good line of products, but the share price seem to go down , could it be due to the weak us dollar.

more than 1 year ago

Two Peaches!!!! (AZN)

(option stock price + price paid) (stock option sell price chnge on day for option) LOG MAY 280 PUT 23+6 263 24 AZN MAY 2600 PUT 104+25 2548 118 THESE WILL MOVE QUICKLY!

more than 1 year ago

FTSE signals (AZN)

FTSE 100 :4410.7+25 @16:36 MAIN S/R 4518 TARGET 4375/1 MINI S/R 4446 TARGET 4357/1 VOL 2850 YIELD 3.26 BAROMETER 32 LONG FTSE FUTURE (JUN 04) ARE @ 4423, 13 POINTS ABOVE CASH AND 1.5 ABOVE FAIR VALUE OF +11.5 DOW @ 10396+39 @ 17:00 (PUT YOUR SHORTS ON!!)

Register now for FREE AstraZeneca share price discussions